Group B streptococcus in pregnancy
Exam relevance: in 6 of more than 150 board exam reports · rank 93
- Synonyms
- GBS, group B strep
- Specialty
- Obstetrics · Pregnancy disorders
- Images
- Histology & cytology 3
- Exam relevance
- 6 of more than 150 reports · rank 93
- In the app
- 1 flashcard · GynFuchs
- Last updated
- 10/2026 · Dr. Pascal Bafteh
Contents
Images (3)
Histology & cytology
Histology & cytology
Histology & cytologyDefinition
- Group B streptococci (Streptococcus agalactiae) are gram-positive bacteria that frequently colonise the genital and gastrointestinal tract asymptomatically.
Classification
- Early-onset disease: it affects newborns in the first 7 days of life.
- Late-onset disease: it occurs from day 7 to day 89 of life.
Occurrence & epidemiology
Why It Matters
- The pathogen: Streptococcus agalactiae (group B).
- Occurrence: colonisation in 10–30% of pregnant women.
- The risk for the infant: early-onset sepsis with pneumonia/meningitis.
Epidemiology
- Up to one third of pregnant women are colonised in the gastrointestinal tract and vagina.
Aetiopathogenesis
Aetiology and pathogenesis
- Early-onset disease arises from vertical transmission during birth, including ascending spread from the vagina.
- The main risk factor is maternal colonisation; the risk also rises with prolonged rupture of membranes and preterm birth.
Clinical features
Clinical features and complications
- In the newborn, both forms present as bacteraemia, sepsis, pneumonia and meningitis; neurological sequelae include loss of sight or hearing and cerebral palsy.
- In the pregnant woman, group B streptococci can cause asymptomatic bacteriuria, urinary tract infection, chorioamnionitis, postpartum endometritis and bacteraemia; preterm birth and stillbirth have also been described.
Diagnosis
- Detection of group B streptococci requires correct specimen collection; besides culture, nucleic acid amplification tests (NAAT) are used.
- Colonisation can change: up to 40% of those testing positive during pregnancy are negative at the time of birth.
Treatment principles
- Women with documented colonisation at the end of pregnancy, or with unknown status and risk factors, receive intravenous intrapartum antibiotic prophylaxis.
- Treating asymptomatic vaginal colonisation before labour is not useful, because it does not eradicate the organisms permanently.
- Depending on prophylaxis and risk profile, the newborn is clinically monitored, and any signs of infection prompt immediate neonatal assessment.
Specific treatment regimens with drugs and doses are covered in the GynFuchs app.
Keep learning in the app
Further reading (selection)
Cross-references
More topics: Pregnancy disorders
Keep learning
Keep learning with flashcards, exam questions and spot diagnoses in the GynFuchs app – free, in your browser or as an app.
Related pages: Chronic hypertension in pregnancy · Diabetic fetopathy and neonatal hypoglycaemia · Threatened preterm birth
Note: Learning content from the GynFuchs app (flashcards, exam questions, image cases) for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.